A qualitative study on the influencing factors of the quality of life of children aged 7–14 with allergic diseases from the perspective of caregivers
摘要
In recent years, the prevalence of allergic diseases among children has been increasing year by year, which has become an important public health issue of global concern. Clarifying the multi-dimensional influencing factors of the quality of life of children with allergic diseases is of vital importance for the precise care of these children.
AimThis study aimed to explore, from the caregivers’ perspective, the multidimensional factors influencing the quality of life of children aged 7–14 with allergic diseases.
MethodsBy using the purposive sampling method, from August to December 2025, 16 main caregivers of children with allergic diseases were selected as the research subjects in a tertiary hospital in Heilongjiang Province, China. One-to-one semi-structured interviews were conducted, and the conversations were transcribed word by word after each interview. We analyzed the data based on Colaizzi’s seven-step analysis method.
ResultsA total of 4 themes and 10 sub-themes were extracted: disease symptoms (symptom distress, sleep, exercise and dietary restrictions), impaired psychological and social functions (negative emotions, limited social participation), family care (protective resistance, caregiver cognitive misunderstandings, family coping failure), and medical support (lack of medical trust, medication and emergency attack guidance needs).
ConclusionChildren’s quality of life emerged not as a product of symptoms alone but as the result of an interacting system in which physical distress, the child’s psychological state, the caregiver’s knowledge and emotional burden, and the responsiveness of the health system continuously shape one another. Improving quality of life therefore calls for care that treats the child and the caregiver as a single unit — combining symptom control with psychological support for the child, structured education and emotional relief for caregivers, and a more accessible, continuous, and trustworthy medical pathway.
Clinical trial numberNot applicable.